SGRY (Surgery Partners) ROCE %: 3.52% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGRY Surgery Partners Inc SGRY
66 GF Score
Price $14.92
GF Value $26.81
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Surgery Partners ROCE %?

Surgery Partners SGRY -2.61% 66 ROCE % is 3.52% as of Mar. 2026. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Surgery Partners's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.52%.

Surgery Partners  (NAS:SGRY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Surgery Partners ROCE % Related Terms

Surgery Partners ROCE % Historical Data

* Premium members only.

The historical data trend for Surgery Partners's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgery Partners ROCE % Chart

Surgery Partners Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.79 5.87 5.23 5.12 5.27

Surgery Partners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 6.05 5.74 5.93 3.52
SGRY
66GF Score
Surgery Partners Inc SGRY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgery Partners ROCE % Calculation

Surgery Partners's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=389.5/( ( (7890 - 624.4) + (8119.7 - 615.5) )/ 2 )
=389.5/( (7265.6+7504.2)/ 2 )
=389.5/7384.9
=5.27 %

Surgery Partners's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=263.2/( ( (8119.7 - 615.5) + (8042.1 - 581.7) )/ 2 )
=263.2/( ( 7504.2 + 7460.4 )/ 2 )
=263.2/7482.3
=3.52 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.52% mean?
Surgery Partners (SGRY) has a ROCE % of 3.52% as of Mar. 2026.
Is Surgery Partners' ROCE % too high?
Surgery Partners' current ROCE % is 3.52%. The Healthcare Providers & Services industry median ROCE % is 6.52. Surgery Partners' value of 3.52% is 46% below this industry median. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' ROCE % compare to AVAH and ASTH?
Surgery Partners' ROCE % of 3.52% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.52. Surgery Partners' value of 3.52% is 46% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.52, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current ROCE % of 3.52% is 46% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current ROCE % is 3.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current ROCE % is 3.52% and 46% below the Healthcare Providers & Services industry median of 6.52. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Surgery Partners (SGRY), the current ROCE % is 3.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgery Partners (SGRY) Overvalued in 2026?

Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued. The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81. GuruFocus considers Surgery Partners to be Possible Value Trap.

Key valuation signals for SGRY:

  • ROCE %: 3.52%
  • GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
  • GF Score™: 66/100 with 4 warning signs
  • Industry Position: 46% below the Healthcare Providers & Services median

No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgery Partners Business Description

Other Exchanges 1SP:Germany
Address 340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score

Get the complete analysis for SGRY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.92
Price
$26.81
GF Value